Provided by Tiger Fintech (Singapore) Pte. Ltd.

CRYO-CELL International, Inc.

5.62
-0.1100-1.92%
Post-market: 5.620.00000.00%16:05 EDT
Volume:7.14K
Turnover:39.74K
Market Cap:45.42M
PE:622.44
High:5.64
Open:5.47
Low:5.39
Close:5.73
Loading ...

Company Profile

Company Name:
CRYO-CELL International, Inc.
Exchange:
AMEX
Establishment Date:
1989
Employees:
84
Office Location:
700 Brooker Creek Boulevard,Suite 1800,Oldsmar,Florida,United States
Zip Code:
34677
Fax:
813 855 4745
Introduction:
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases. The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.

Directors

Name
Position
David I. Portnoy
Chairman and Co-Chief Executive Officer
Mark L. Portnoy
Co-Chief Executive Officer and Director
Daniel Mizrahi
Director
Harold D. Berger
Director

Shareholders

Name
Position
David I. Portnoy
Chairman and Co-Chief Executive Officer
Mark L. Portnoy
Co-Chief Executive Officer and Director
Jill Taymans
Vice President, Finance and Chief Financial Officer
Oleg Mikulinsky
Chief Information Officer